Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Advances in Radiation Oncology|February 13, 2026
Safety and Efficacy of External Beam Radiation Therapy in Hepatocellular Carcinoma Patients Previously Treated With Yttrium 90 Transarterial RadioembolizationKanokphorn Thonglert, Joseph Tsai, Wayne L Monsky, et al.EJNMMI Research|June 29, 2016
Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patientsStephen R Bowen, Tobias R Chapman, Joshua Borgman, et al.Practical Radiation Oncology|August 2, 2015
Metrics of success: Measuring impact of a departmental near-miss incident learning systemMatthew J Nyflot, Jing Zeng, Aaron S Kusano, et al.Medical Physics|June 29, 2023
AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QANesrin Dogan, Ben J Mijnheer, Kyle Padgett, et al.Clinical and Translational Radiation Oncology|August 8, 2025
Simultaneous integrated boost and protection proton beam therapy approach for hepatocellular carcinomaKanokphorn Thonglert, Matthew D Greer, Stephanie K Schaub, et al.Skeletal Radiology|June 30, 2026
MRI-Based radiomic signature for predicting pathologic treatment response to neoadjuvant chemoradiotherapy and radioimmunotherapy in soft tissue sarcomaMajid Chalian, Ehsan Alipour, Atefe Pooyan, et al.Journal of Applied Clinical Medical Physics|April 14, 2016
Electron beam energy QA - a note on measurement tolerancesJuergen Meyer, Matthew J Nyflot, Wade P Smith, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2019
CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapyJan C Peeken, Michael Bernhofer, Matthew B Spraker, et al.Practical Radiation Oncology|February 11, 2018
Toward consensus reporting of radiation-induced liver toxicity in the treatment of primary liver malignancies: Defining clinically relevant endpointsTobias R Chapman, Stephen R Bowen, Stephanie K Schaub, et al.International Journal of Radiation Oncology, Biology, Physics|February 10, 2015
Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusionMatthew J Nyflot, Tim J Kruser, Anne M Traynor, et al.Pageof 5